Geneva, Switzerland (PRWEB UK) 25 June 2013
The Presidents of the Healthtech Summit, Aris Constantinides, NBGI Ventures and Rudy Mareel, former CEO of Synthon, and the Vice President of the Selection Committee, Joey Mason, Delta Partners, announce today the names of the top 20 European healthtech companies as selected by an expert committee to present at the NYSE Euronext in London. Joey Mason commented on the selection process saying, “This year's selection committee rose to the tough task of choosing from a highly diverse pool of truly innovative medical technology companies from Europe and Israel. Our pleasurable challenge was to select the small group of presenting companies from what is a vibrant and growing sector.”
Top 20 Presenting Companies:
Aleva Neurotherapeutics, Apica Cardiovascular, Calon Cardio-Technology, Cambridge Cognition,
Check-cap, Mainstay Medical, Medlumics, Microtest Diagnostics, Microvisk, MindMaze, Nuubo, Pixium Vision, Quanta Fluid Solutions, Radius Diagnostics, Sequana Medical, SpineGuard, Synoste, TNI Medical, Vimecon, Vivasure Medical.
The nominated companies represent 8 countries in various stages of development ranging from seed to expansion from a variety of Healthtech arenas including: 25% Cardiology, 25% Diagnostics & Monitoring, 20% Medical Devices,15% Neurology, 10% Orthopedic, and 5% Ophthalmology.
The 2013 Healthtech Summit will feature the second Salus Partners Excellence in Healthtech Award; celebrating the success of companies who have consistently demonstrated excellence in the sector. From the hundreds of companies that have applied to the Medtech and Healthtech Summits, a total of 68 companies were chosen from 14 countries for a chance to be selected for the Excellence in Healthtech Award. This pool of Alumni has made significant progress in bringing new technology innovation to the healthcare markets with 60% of the companies achieving the CE mark for introduction of their product in Europe, and 24% having additionally received FDA approval for market entry into the United States. Cumulatively these companies raised a total of over 568.4M Euro in capital and over 325.9M Euro was raised after the presentation of the companies at one or more of the Summits.
The award selection committee has chosen EOS Imaging for sustainable growth and development from among three alumni who have to date been listed on public exchanges. The CEO of EOS Imaging Dr. Marie Meynadier will be present at the gala dinner of the Summit to receive the award on behalf of the company.
A delegation of 140 leading global industry players and representatives from cross-venture capital and global investment firms are attending the event. Estimated investment capabilities of attending investors are estimated to 5 billion+ Euros.
For more information please visit: http://www.healthtechsummit.eu.
+41 22 544 60 62
About the Tech Tour
The Tech Tour was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. The Tech Tour is an independent, not-for-profit organization composed of key contributors to the high technology industry. The organization recognizes that continued prosperity in Europe lies in its ability to transform today's innovative projects into tomorrow's global technology leaders.
About the International Venture Club
The International Venture Club was founded in 2011 as the collaborative platform of leading venture investors promoting successful international investments. Its objectives are to 1) share better practices, 2) build co-investor trust and relations, 3) foster new funding and investment opportunities through joint actions and PR, 4) grow promising companies with corporate partners and co-investors and 5) keep a smart window and support to emerging innovative companies.